glp-1 off label Ozempic and Other Off-Label Drugs for Type 1 Diabetes Weight Management Advanced Appetite Control Off-Label' Dosing to Personalize GLP-1
Description
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for managing type 2 diabetes, though some are now also licensed for weight management
They bring an extra 2 grams of protein and 4 grams of fiber to the table

Acute glucose fluctuation impacts microglial activity, leading to inflammatory activation or self-degradation

However, this risk is generally manageable through gradual dose escalation, adequate hydration, and monitoring of digestive symptomssteps that PlexusDx treatment protocols already include

For a 12-week maintenance phase, budget 7-8 vials of 20mg

Gastrointestinal adverse events leading to treatment discontinuation occur in approximately 4-5% of patients on Wegovy, with diarrhea being one contributing factor
